SCHEMBL8212151

SCHEMBL8212151

CN1CCN(CCC(=O)N2CCC(=NOCc3cccc(C(F)(F)F)c3)CC2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.45
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
LMNA P02545 3/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
GALR3 O60755 1/20 0.39
FAAH O00519 1/20 0.39
HRH4 Q9H3N8 1/20 0.39
MAOB P27338 2/20 0.39
MC4R P32245 1/20 0.39
POLB P06746 2/20 0.38
MAPT P10636 1/20 0.38
KDM1A O60341 1/20 0.38
MAOA P21397 1/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4383617 0.99 KMT2A (0.44) KMT2AMEN1CARM1PRMT6LMNA
SCHEMBL4393097 0.93 KMT2A (0.43) KMT2AMEN1CARM1PRMT6LMNA
SCHEMBL8221599 0.93 KMT2A (0.45) KMT2AMEN1CARM1PRMT6LMNA
Hydrochloric Acid SCHEMBL4376998 0.92 KMT2A (0.45) KMT2AMEN1CARM1PRMT6LMNA
SCHEMBL8218596 0.90 KMT2A (0.48) KMT2AMEN1LMNAKDM4EGAA
SCHEMBL8218922 0.89 HTR7 (0.52) KMT2ALMNAALDH1A1POLBMAPT
Hydrochloric Acid SCHEMBL4387884 0.89 KMT2A (0.48) KMT2AMEN1LMNAKDM4EGAA
SCHEMBL8218601 0.89 CARM1 (0.43) KMT2AMEN1CARM1PRMT6ALDH1A1
Hydrochloric Acid SCHEMBL4384778 0.88 HTR7 (0.51) KMT2ALMNAALDH1A1POLBMAPT
Hydrochloric Acid SCHEMBL4382723 0.88 CARM1 (0.43) KMT2AMEN1CARM1PRMT6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF PURDUE PHARMA L.P. 2009-12-03 US disclosed
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF PURDUE PHARMA L.P. 2009-12-03 US disclosed
WO-2008008398-A2 OXIME COMPOUNDS AND THE USE THEREOF SHIONOGI & CO., LTD. (JP) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF KCNN4, CACNA1A, KCNN3 KMT2A 2079/4885MEN1 3694/4885CARM1 1775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.